Cargando…
An optimized HMGB1 expressed by recombinant rabies virus enhances immunogenicity through activation of dendritic cells in mice
Rabies remains an important public health threat, killing approximately 59,000 people worldwide annually, most of which are from the developing countries of Africa and Asia where dog rabies are endemic. Therefore, developing an affordable and efficacious vaccine for dog-mediated rabies control is ne...
Autores principales: | Wang, Zhao, Liang, Qian, Zhang, Yajing, Yang, Jie, Li, Mingming, Wang, Kunlun, Cui, Min, Chen, Huanchun, Fu, Zhen F., Zhao, Ling, Zhou, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663534/ https://www.ncbi.nlm.nih.gov/pubmed/29137362 http://dx.doi.org/10.18632/oncotarget.18368 |
Ejemplares similares
-
Recombinant rabies virus with the glycoprotein fused with a DC-binding peptide is an efficacious rabies vaccine
por: Zhang, Yachun, et al.
Publicado: (2017) -
Recombinant rabies virus expressing dog GM-CSF is an efficacious oral rabies vaccine for dogs
por: Zhou, Ming, et al.
Publicado: (2015) -
Safety and immunogenicity of recombinant rabies virus (ERAGS) in mice and raccoon dogs
por: Yang, Dong-Kun, et al.
Publicado: (2016) -
Immunization with recombinant rabies virus expressing Interleukin-18 exhibits enhanced immunogenicity and protection in mice
por: Gai, Weiwei, et al.
Publicado: (2017) -
A novel oral rabies vaccine enhances the immunogenicity through increasing dendritic cells activation and germinal center formation by expressing U-OMP19 in a mouse model
por: Zhao, Jianqing, et al.
Publicado: (2021)